Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma
NCT02099292
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
103
Enrollment
OTHER
Sponsor class
Conditions
Relapsed Non-Hodgkin-Lymphoma
Interventions
DRUG:
Rituximab and DexaBEAM
Sponsor
Georg Hess, MD
Collaborators
[object Object]
[object Object]